Altered levels of phospholipases C, diacylglycerols, endocannabinoids, and N‐acylethanolamines in patients with hereditary angioedema due to FXII mutation

Documenti analoghi

• Prediction of hereditary angioedema during attacks in patients with recurrent angioedema: Awareness at a glance with the hereditary angioedema prediction score
  di: Semra Demir, et al.
  Pubblicazione: (2025)
• Effective long‐term prophylaxis with lanadelumab in adolescents with hereditary angioedema: EMPOWER / ENABLE
  di: Raffi Tachdjian, et al.
  Pubblicazione: (2025)
• Advent of oral medications for the treatment of hereditary angioedema
  di: Anna Valerieva, et al.
  Pubblicazione: (2024)
• Garadacimab for the long‐term prophylaxis of hereditary angioedema
  di: Emel Aygören‐Pürsün, et al.
  Pubblicazione: (2026)
• Human PHOSPHO1 exhibits phosphatidylcholine‐ and phosphatidylethanolamine‐phospholipase C activities and interacts with diacylglycerol kinase δ
  di: Chiaki Murakami, et al.
  Pubblicazione: (2025)